Literature DB >> 23921845

Smoking and smoking cessation in relation to the development of co-existing non-small cell lung cancer with chronic obstructive pulmonary disease.

Rihong Zhai1, Xiaojin Yu, Yongyue Wei, Li Su, David C Christiani.   

Abstract

Previous studies have identified a mixed-phenotype of non-small cell lung cancer (NSCLC) with co-existing chronic obstructive pulmonary disease (COPD). Although NSCLC and COPD share a common risk factor in smoking, whether and how smoking may contribute to the coexistence of NSCLC with COPD (NSCLC-COPD) is unclear. Our study suggests that cigarette smoking is the major risk factor for the development of NSCLC-COPD, especially in females and among patients with squamous cell carcinoma subtype.
© 2013 UICC.

Entities:  

Keywords:  cigarette smoking; co-existing chronic obstructive pulmonary disease; non-small cell lung cancer; risk; smoking cessation

Mesh:

Year:  2013        PMID: 23921845      PMCID: PMC4008140          DOI: 10.1002/ijc.28414

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  50 in total

1.  Development and validation of a survey-based COPD severity score.

Authors:  Mark D Eisner; Laura Trupin; Patricia P Katz; Edward H Yelin; Gillian Earnest; John Balmes; Paul D Blanc
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

2.  Reversal of risk upon quitting smoking.

Authors:  Carolyn M Dresler; Maria E León; Kurt Straif; Robert Baan; Béatrice Secretan
Journal:  Lancet       Date:  2006-07-29       Impact factor: 79.321

3.  Prevalence of COPD in women compared to men around the time of diagnosis of primary lung cancer.

Authors:  Raghu S Loganathan; Diane E Stover; Weiji Shi; Ennapadam Venkatraman
Journal:  Chest       Date:  2006-05       Impact factor: 9.410

4.  Gender differences in COPD: are women more susceptible to smoking effects than men?

Authors:  Inga-Cecilie Sørheim; Ane Johannessen; Amund Gulsvik; Per S Bakke; Edwin K Silverman; Dawn L DeMeo
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

5.  Mortality in women and men in relation to smoking.

Authors:  E Prescott; M Osler; P K Andersen; H O Hein; K Borch-Johnsen; P Lange; P Schnohr; J Vestbo
Journal:  Int J Epidemiol       Date:  1998-02       Impact factor: 7.196

6.  Women's susceptibility to tobacco carcinogens and survival after diagnosis of lung cancer.

Authors:  Claudia I Henschke; Rowena Yip; Olli S Miettinen
Journal:  JAMA       Date:  2006-07-12       Impact factor: 56.272

7.  A chronic obstructive pulmonary disease related signature in squamous cell lung cancer.

Authors:  Mirjam C Boelens; Adam M Gustafson; Dirkje S Postma; Klaas Kok; Gerben van der Vries; Pieter van der Vlies; Avrum Spira; Marc E Lenburg; Marie Geerlings; Hannie Sietsma; Wim Timens; Anke van den Berg; Harry J M Groen
Journal:  Lung Cancer       Date:  2010-09-15       Impact factor: 5.705

8.  Impaired lung function and lung cancer incidence in a cohort of Swedish construction workers.

Authors:  Mark P Purdue; Laura Gold; Bengt Järvholm; Michael C R Alavanja; Mary H Ward; Roel Vermeulen
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

9.  Developing COPD: a 25 year follow up study of the general population.

Authors:  A Løkke; P Lange; H Scharling; P Fabricius; J Vestbo
Journal:  Thorax       Date:  2006-11       Impact factor: 9.139

10.  Female smokers beyond the perimenopausal period are at increased risk of chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Authors:  Wen Qi Gan; S F Paul Man; Dirkje S Postma; Patricia Camp; Don D Sin
Journal:  Respir Res       Date:  2006-03-29
View more
  24 in total

1.  Novel genetic variants in KIF16B and NEDD4L in the endosome-related genes are associated with nonsmall cell lung cancer survival.

Authors:  Sen Yang; Dongfang Tang; Yu C Zhao; Hongliang Liu; Sheng Luo; Thomas E Stinchcombe; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Qiming Wang; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-12-19       Impact factor: 7.396

2.  Potentially functional genetic variants in PLIN2, SULT2A1 and UGT1A9 genes of the ketone pathway and survival of nonsmall cell lung cancer.

Authors:  Dongfang Tang; Yu C Zhao; Hongliang Liu; Sheng Luo; Jeffrey M Clarke; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Wen Gao; Qingyi Wei
Journal:  Int J Cancer       Date:  2020-03-09       Impact factor: 7.396

3.  Pathway-analysis of published genome-wide association studies of lung cancer: A potential role for the CYP4F3 locus.

Authors:  Jieyun Yin; Hongliang Liu; Zhensheng Liu; Kouros Owzar; Younghun Han; Li Su; Yongyue Wei; Rayjean J Hung; Yonathan Brhane; John McLaughlin; Paul Brennan; Heike Bickeboeller; Albert Rosenberger; Richard S Houlston; Neil Caporaso; Maria Teresa Landi; Joachim Heinrich; Angela Risch; David C Christiani; Christopher I Amos; Qingyi Wei
Journal:  Mol Carcinog       Date:  2017-02-23       Impact factor: 4.784

4.  Novel Variants of ELP2 and PIAS1 in the Interferon Gamma Signaling Pathway Are Associated with Non-Small Cell Lung Cancer Survival.

Authors:  Yu Chen Zhao; Dongfang Tang; Sen Yang; Hongliang Liu; Sheng Luo; Thomas E Stinchcombe; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-06-03       Impact factor: 4.254

5.  Potentially functional variants of HBEGF and ITPR3 in GnRH signaling pathway genes predict survival of non-small cell lung cancer patients.

Authors:  Yufeng Wu; Zhensheng Liu; Dongfang Tang; Hongliang Liu; Sheng Luo; Thomas E Stinchcombe; Carolyn Glass; Li Su; Lijuan Lin; David C Christiani; Qiming Wang; Qingyi Wei
Journal:  Transl Res       Date:  2021-01-02       Impact factor: 7.012

6.  Genetic variants in ABCG1 are associated with survival of nonsmall-cell lung cancer patients.

Authors:  Yanru Wang; Hongliang Liu; Neal E Ready; Li Su; Yongyue Wei; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2016-01-30       Impact factor: 7.396

7.  Genetic variants in RUNX3, AMD1 and MSRA in the methionine metabolic pathway and survival in nonsmall cell lung cancer patients.

Authors:  Ka Chen; Hongliang Liu; Zhensheng Liu; Sheng Luo; Edward F Patz; Patricia G Moorman; Li Su; Sipeng Shen; David C Christiani; Qingyi Wei
Journal:  Int J Cancer       Date:  2019-02-01       Impact factor: 7.396

8.  Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.

Authors:  Yinghui Xu; Hongliang Liu; Shun Liu; Yanru Wang; Jichun Xie; Thomas E Stinchcombe; Li Su; Ruyang Zhang; David C Christiani; Wei Li; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-09-21       Impact factor: 7.396

9.  Potentially functional variants of ERAP1, PSMF1 and NCF2 in the MHC-I-related pathway predict non-small cell lung cancer survival.

Authors:  Sen Yang; Dongfang Tang; Yu Chen Zhao; Hongliang Liu; Sheng Luo; Thomas E Stinchcombe; Carolyn Glass; Li Su; Sipeng Shen; David C Christiani; Qiming Wang; Qingyi Wei
Journal:  Cancer Immunol Immunother       Date:  2021-03-02       Impact factor: 6.968

10.  Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival.

Authors:  Hailei Du; Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Mulong Du; David C Christiani; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.